07.11.2016 • NewsABSAutomotive industryDede Willams

Trinseo to Produce ABS in China

Trinseo’s MAGNUM™ ABS Resins (left side of photo) as compared to...
Trinseo’s MAGNUM™ ABS Resins (left side of photo) as compared to competitors’ emulsion ABS resins manufactured in China.

Trinseo, the former Dow Chemical styrenics business, will begin production of ABS resin at its Zhangjiagang, China, site in 2017. The Chinese production will use the US company’s proprietary process technology, which it said yields ABS of superior quality compared to competitive ABS resins currently produced in China and at lower cost.

The company said its Magnum brand ABS delivers greater product stability, which can reduce costs for molding, compounding, extrusion, and thermoforming in numerous applications. Production of ABS in Zhangjiagang reinforces Trinseo’s long-term goal of having local production of its global products for the automotive industry in all major regions, thus supporting the company’s global partnerships with major OEMs, said Dagmar van Heur, vice president, Performance Plastics.

In late September, Trinseo became an independent publicly listed company after private equity firm Bain Capital sold its remaining stake.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.